Evidence map›Paper›PMID 38408202›Full record

ArticleCardiology journal2024

Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).

Dominika Klimczak-Tomaniak, Karolina Andrzejczyk, Sabrina Abou Kamar, Sara Baart, Nick van Boven, K Martijn Akkerhuis, Alina Constantinescu, Kadir Caliskan, Suat Simsek, Tjeerd Germanse and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cardiology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Dominika Klimczak-TomaniakDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Karolina AndrzejczykDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Sabrina Abou KamarDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Sara BaartDepartment of Biostatistics, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Nick van BovenDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
K Martijn AkkerhuisDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Alina ConstantinescuDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Kadir CaliskanDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Suat SimsekDepartment of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.
Tjeerd GermanseDepartment of Cardiology, Northwest Clinics, Alkmaar, The Netherlands.
Jan van RamshorstDepartment of Cardiology, Northwest Clinics, Alkmaar, The Netherlands.
Jasper BrugtsDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Marek KuchDepartment of Cardiology, Hypertension and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Victor UmansDepartment of Cardiology, Northwest Clinics, Alkmaar, The Netherlands.
Eric BoersmaDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Isabella KardysDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands. i.kardys@erasmusmc.nl.
Erasmus MC · NLNorthwest Hospital · USMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver dysfunction contributes to worse clinical outcomes in heart failure (HF) patients. However, studies exploring temporal evolutions of liver function parameters in chronic HF (CHF) pa- tients, and their associations with clinical outcome, are scarce. Detailed temporal patterns of alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGTP), total bilirubin (TBIL) and albumin (ALB) were investigated, and their relation with clinical outcome, in patients with stable CHF with reduced ejection fraction.

methodsTri-monthly plasma samples were collected from 250 patients during 2.2 (1.4-2.5) years of follow-up. ALP, GGTP, ALB, and TBIL were measured in 749 selected samples and the relationship between repeatedly measured biomarker levels and the primary endpoint (PEP; composite of cardiovas- cular death, heart transplantation, left ventricular assist device implantation, and hospitalization for worsened HF) was evaluated by joint models.

resultsMean age was 66 ± 13 years; 74% were men, 25% in New York Heart Association class III-IV. 66 (26%) patients reached the PEP. Repeatedly measured levels of TBIL, ALP, GGTP, and ALB were associated with the PEP after adjustment for N-terminal prohormone B-type natriuretic peptide and high sensitivity troponin T (hazard ratio [95% confidence interval] per doubling of biomarker level: 1.98 [1.32; 2.95], p = 0.002; 1.84 [1.09; 3.05], p = 0.018, 1.33 [1.08; 1.63], p = 0.006 and 1.14 [1.09; 1.20], p < 0.001, respectively). Serial levels of ALP and GGTP, and slopes of the temporal evolutions of ALB and TBIL, adjusted for clinical variables, were also significantly associated with the PEP.

conclusionsChanges in serum levels of TBIL, ALP, GGTP, and ALB precede adverse cardiovascular events in patients with CHF. These routine liver function parameters may provide additional prognostic information in heart failure with reduced ejection fraction patients in clinical practice.

Indexed as

BiomarkersHeart FailureLiver Function TestsAgedAlkaline PhosphataseBilirubinChronic DiseaseFemaleFollow-Up Studiesgamma-GlutamyltransferaseHumansLiverMaleMiddle AgedPredictive Value of TestsPrognosisAlkaline PhosphataseBilirubinBiomarkersgamma-Glutamyltransferasebiomarkersheart failureheart failure with reduced ejection fractionliverrisk assessment

Identifiers

PMID38408202
PMCPMC11229812
OpenAlexW4392153848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.